首页> 外文OA文献 >Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia : results from the 24-month follow-up of the BELA trial

【2h】

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia : results from the 24-month follow-up of the BELA trial

机译：博舒替尼与伊马替尼治疗新诊断的慢性期慢性粒细胞白血病：BELA试验24个月的随访结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Brümmendorf, Tim Henrik; Cortes, Jorge E.; de Souza, Cármino Antonio; Guilhot, Francois; Duvillié, Ladan; Pavlov, Dmitri; Gogat, Karïn; Countouriotis, Athena M.; Gambacorti-Passerini, Carlo;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial. [J] . Tim H Brümmendorf, Jorge E Cortes, Cármino Antonio de Souza, British Journal of Haematology . 2015,第1期

机译：博舒替尼与伊马替尼治疗新诊断的慢性期慢性粒细胞白血病：BELA试验24个月的随访结果。
2. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: Results from the BELA trial [J] . CortesJ.E., KimD.-W., KantarjianH.M., Journal of Clinical Oncology . 2012,第28期

机译：博舒替尼与伊马替尼在新诊断的慢性期慢性粒细胞白血病中的作用：BELA试验的结果
3. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial. [J] . Kantarjian HM, Hochhaus A, Saglio G, The lancet oncology . 2011,第9期

机译：尼罗替尼与伊马替尼治疗新诊断的慢性期，费城染色体阳性，慢性粒细胞白血病的患者：3期随机ENESTnd试验的至少24个月随访。
4. Combination effects of repetitive pulsed magnetic stimulation and tyrosine kinase inhibitor imatinib for chronic myeloid leukemia cell line TCC-S [C] . S. Yamaguchi, M. Sekino, Y. Sato, Intermag Conference . 2006

机译：重复脉冲磁刺激和酪氨酸激酶抑制剂慢性髓性白血病细胞系TCC-S的组合效应
5. Influences on physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia patients. [D] . Iyer, Shrividya Sethuraman. 2003

机译：对慢性期慢性粒细胞白血病患者甲磺酸伊马替尼的医师推荐的影响。
6. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial [O] . Tim H Brümmendorf, Jorge E Cortes, Cármino Antonio de Souza, -1

机译：博舒替尼与伊马替尼治疗新诊断的慢性期慢性粒细胞白血病：BELA试验24个月的随访结果
7. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial [O] . Cortés, Jorge Eduardo, Kim, Dong-Wook, Gambacorti-Passerini, Carlo, 2012

机译：博舒替尼与伊马替尼治疗新诊断的慢性期慢性粒细胞白血病：BELA试验的结果

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia : results from the 24-month follow-up of the BELA trial

著录项

相似文献

相关主题

期刊订阅